[{"Assets_0_Q3_USD":585636000.0,"CommonStockSharesOutstanding_0_Q3_shares":47199907.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":36110000.0,"NetIncomeLoss_1_Q3_USD":1310000.0,"NetIncomeLoss_3_Q3_USD":49965000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":47239000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":47030000.0,"StockholdersEquity_0_Q3_USD":389405000.0,"EarningsPerShareBasic_1_Q3_USD":0.03,"EarningsPerShareBasic_3_Q3_USD":1.06,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]